Akero Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
3.23 |
19.34 |
63.40 |
157.00 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
499.51% |
227.79% |
147.63% |
| Przychód (min) |
0.00 |
0.00 |
3.23 |
19.34 |
63.40 |
157.00 |
| Przychód (max) |
0.00 |
0.00 |
3.23 |
19.34 |
63.40 |
157.00 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-269.44 |
-254.75 |
-297.74 |
-428.13 |
-281.30 |
-93.32 |
| Zysk netto % |
-inf% |
-inf% |
-9228.53% |
-2213.49% |
-443.70% |
-59.44% |
| EPS (średnia) |
-3.97 |
-3.79 |
-4.36 |
-5.03 |
-4.19 |
-1.39 |
| Liczba analityków (Przychody) |
0 |
0 |
4 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
8 |
7 |
6 |
3 |
1 |
1 |
| symbol |
AKRO |
AKRO |
AKRO |
AKRO |
AKRO |
AKRO |